143 related articles for article (PubMed ID: 17456217)
1. A proof-of-concept study to assess the putative dose response to topical corticosteroid in persistent allergic rhinitis using adenosine monophosphate challenge.
Barnes ML; Menzies D; Nair AR; Hopkinson PJ; Lipworth BJ
Clin Exp Allergy; 2007 May; 37(5):696-703. PubMed ID: 17456217
[TBL] [Abstract][Full Text] [Related]
2. The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis.
Skoner DP; Gentile D; Angelini B; Kane R; Birdsall D; Banerji D
Ann Allergy Asthma Immunol; 2003 Jan; 90(1):56-62. PubMed ID: 12546339
[TBL] [Abstract][Full Text] [Related]
3. Effects of intranasal corticosteroid on nasal adenosine monophosphate challenge in persistent allergic rhinitis.
Barnes ML; Biallosterski BT; Fujihara S; Gray RD; Fardon TC; Lipworth BJ
Allergy; 2006 Nov; 61(11):1319-25. PubMed ID: 17002709
[TBL] [Abstract][Full Text] [Related]
4. Comparative safety and efficacy of 2 formulations of fluticasone aqueous nasal spray in persistent allergic rhinitis.
Vaidyanathan S; Barnes M; Lipworth BJ
Ann Allergy Asthma Immunol; 2009 Jan; 102(1):76-83. PubMed ID: 19205290
[TBL] [Abstract][Full Text] [Related]
5. Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis.
Lee DK; Jackson CM; Soutar PC; Fardon TC; Lipworth BJ
Br J Clin Pharmacol; 2004 Jun; 57(6):714-9. PubMed ID: 15151516
[TBL] [Abstract][Full Text] [Related]
6. A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis.
Lee DK; Gray RD; Robb FM; Fujihara S; Lipworth BJ
Clin Exp Allergy; 2004 Apr; 34(4):646-9. PubMed ID: 15080820
[TBL] [Abstract][Full Text] [Related]
7. Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis.
Bernstein DI; Levy AL; Hampel FC; Baidoo CA; Cook CK; Philpot EE; Rickard KA
Clin Exp Allergy; 2004 Jun; 34(6):952-7. PubMed ID: 15196285
[TBL] [Abstract][Full Text] [Related]
8. Effects of levocetirizine as add-on therapy to fluticasone in seasonal allergic rhinitis.
Barnes ML; Ward JH; Fardon TC; Lipworth BJ
Clin Exp Allergy; 2006 May; 36(5):676-84. PubMed ID: 16650054
[TBL] [Abstract][Full Text] [Related]
9. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis.
Gradman J; Caldwell MF; Wolthers OD
Clin Ther; 2007 Aug; 29(8):1738-47. PubMed ID: 17919555
[TBL] [Abstract][Full Text] [Related]
10. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study.
Rimmer J; Peake HL; Santos CM; Lean M; Bardin P; Robson R; Haumann B; Loehrer F; Handel ML
Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis.
Lee DK; Gardiner M; Haggart K; Fujihara S; Lipworth BJ
Clin Exp Allergy; 2004 Apr; 34(4):650-3. PubMed ID: 15080821
[TBL] [Abstract][Full Text] [Related]
12. Histamine releasability after adenosine challenge in subjects with allergic and non-allergic rhinitis: possible implications for mast cell priming.
Polosa R; Pagano C; Low JL; Church MK; Crimi N
Ann Ital Med Int; 1999; 14(2):86-93. PubMed ID: 10399370
[TBL] [Abstract][Full Text] [Related]
13. Effect of levocetirizine on nasal provocation testing with adenosine monophosphate compared with allergen challenge in allergic rhinitis.
Vaidyanathan S; Nair A; Barnes ML; Meldrum K; Lipworth BJ
Clin Exp Allergy; 2009 Mar; 39(3):409-16. PubMed ID: 19187327
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of an intranasal house dust mite provocation model as a tool in clinical research.
Oldenbeuving NB; KleinJan A; Mulder PG; Lumley P; de Groot EJ; van Drunen CM; Fokkens WJ
Allergy; 2005 Jun; 60(6):751-9. PubMed ID: 15876304
[TBL] [Abstract][Full Text] [Related]
15. Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber.
Zieglmayer P; Zieglmayer R; Bareille P; Rousell V; Salmon E; Horak F
Curr Med Res Opin; 2008 Jun; 24(6):1833-40. PubMed ID: 18498678
[TBL] [Abstract][Full Text] [Related]
16. Intranasal fluticasone propionate is effective for perennial nonallergic rhinitis with or without eosinophilia.
Webb DR; Meltzer EO; Finn AF; Rickard KA; Pepsin PJ; Westlund R; Cook CK
Ann Allergy Asthma Immunol; 2002 Apr; 88(4):385-90. PubMed ID: 11995670
[TBL] [Abstract][Full Text] [Related]
17. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen.
Fokkens WJ; Jogi R; Reinartz S; Sidorenko I; Sitkauskiene B; van Oene C; Faris MA; Ellsworth A; Caldwell MF
Allergy; 2007 Sep; 62(9):1078-84. PubMed ID: 17686111
[TBL] [Abstract][Full Text] [Related]
18. Combined mediator blockade or topical steroid for treating the unified allergic airway.
Barnes ML; Menzies D; Fardon TC; Burns P; Wilson AM; Lipworth BJ
Allergy; 2007 Jan; 62(1):73-80. PubMed ID: 17156345
[TBL] [Abstract][Full Text] [Related]
19. Effects of butterbur treatment in intermittent allergic rhinitis: a placebo-controlled evaluation.
Gray RD; Haggart K; Lee DK; Cull S; Lipworth BJ
Ann Allergy Asthma Immunol; 2004 Jul; 93(1):56-60. PubMed ID: 15281472
[TBL] [Abstract][Full Text] [Related]
20. Effective treatment of mild-to-moderate nasal polyposis with fluticasone delivered by a novel device.
Vlckova I; Navrátil P; Kana R; Pavlicek P; Chrbolka P; Djupesland PG
Rhinology; 2009 Dec; 47(4):419-26. PubMed ID: 19936370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
